CHG-2023-0238

New Dosage Strength for Crizotinabex. New Dosage Strength for Crizotinabex — minor update. Impacts 3 markets and 4 variations.

Change Number
CHG-2023-0238
Type
New Dosage Strength
Product
Crizotinabex
Status
Submitted
Owner
James O'Brien
Initiated
2023-09-13
Description

New Dosage Strength for Crizotinabex — minor update

Impacted Markets (3)
CN — ChinaES — SpainTR — Turkey
Impacted Modules
5.3.53.2.P3.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved